Teva launches generic Remodulin injection

Press enter to search
Close search
Open Menu

Teva launches generic Remodulin injection

By David Salazar - 10/01/2019
Teva Remodulin

Teva Pharmaceuticals has launched its generic of Remodulin (trepostinil) injection. The drug is indicated to treat pulmonary arterial hypertension. 

Teva’s generic Remodulin is available in multi-dose 20 ml vials in dosage strengths of 1 mg/ml, 2.5 mg/ml, 5 mg/ml and 10 mg/ml. 

RELATED TOPICS